NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,890
-30 (-0.22%)
At close: Mar 28, 2025, 3:30 PM KST
-29.95%
Market Cap 151.31B
Revenue (ttm) 24.55B
Net Income (ttm) -9.33B
Shares Out 10.89M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,344
Average Volume 40,245
Open 13,920
Previous Close 13,920
Day's Range 13,650 - 14,050
52-Week Range 13,650 - 25,850
Beta 0.87
RSI 32.10
Earnings Date n/a

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 35
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.

Financial Statements

News

There is no news available yet.